Antibodies to aquaporin-1 are not present in neuromyelitis optica

Although more than 70% of all patients with neuromyelitis optica (NMO) are seropositive for aquaporin-4 (AQP4) antibodies, a substantial proportion of patients fulfilling the clinical criteria for NMO or limited forms of the disease (NMO spectrum disorders [NMOSD]) are negative for these antibodies....

Descripció completa

Dades bibliogràfiques
Autors principals: Waters, P, Leite, M, Palace, J
Format: Journal article
Publicat: American Academy of Neurology 2015